Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)

NCT02838693 is registered in ClinicalTrials.gov with Medicine as lead sponsor.

NCT NCT02838693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02838693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes)
Lead sponsor
Medicine
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2016
Completion date
December 31, 2021
Enrollment
2,300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, pre-diabetes